• Updated Version in Latest Forum Annals •
A revised and updated HCV drug resistance report, published by the Forum’s HCV DrAG is now available. The report is intended as a systematic and comprehensive one-stop information source for researchers, clinicians and the HCV community at large. The report’s table and appendix summarize information obtained in vitro, whereas the figure summarizes information observed in clinical trials.
A volunteer panel of stakeholders from the DrAG’s Phenotype Working Group with expertise in HCV virology and clinical outcomes performed a detailed review of published data and reached consensus on resistance mutations to be included in the figure and tables. Regular updates to the Figure and Table are planned to keep pace with emerging drug resistance data from HCV drug discovery programs and the outcome of clinical tests.